Pfizer Is Still Struggling to Replace Its COVID Revenue. Here's What We Could See From the Pharmaceutical Giant in 2026. Keep ...

Analysts are intrested in these 5 stocks: ( ($LEN) ), ( ($PFE) ), ( ($NET) ), ( ($SYM) ) and ( ($WDAY) ). Here is a breakdown of their recent ...

New additions enable clients to better connect pre-launch strategy through in-market execution-aligning intelligence and teams to drive effective launches and more cohesive customer engagement ...

Panelists at this month's Microsoft Ignite event talked about their efforts to roll out agentic AI at their companies, ...

Abstract: Predicting Customer Lifetime Value (CLV) is one of the most critical tasks that businesses undertake in order to improve customer retention and optimize marketing strategies. The present ...

Pfizer has released the full data from its phase 3 trial of an mRNA flu vaccine candidate, with the potential new shot demonstrating 34.5% greater efficacy compared to a control vaccine. Of 9,225 ...

Gaining customer trust has long been cherished among executive teams as a way to build brand value. Traditional metrics have been central for managing customer trust. But digital media and associated ...

Pfizer’s mRNA flu vaccine outperformed the standard flu shot in a Phase 3 clinical trial, according to results published Wednesday in the New England Journal of Medicine. The vaccine uses the same ...

Nov 19 (Reuters) - Pfizer (PFE.N), opens new tab and supplier Tris Pharma reached a $41.5 million settlement with Texas to resolve a lawsuit claiming they defrauded the state's Medicaid program over ...

Pfizer is buying out Metsera for up to $10 billion after an acquisition battle with another pharma giant. Metsera's leading candidate could be an excellent way for Pfizer to enter the weight-loss drug ...